AIM ImmunoTech News

AIM ImmunoTech Analyst Ratings

BenzingaOct 22 17:29 ET

Maxim Group Maintains AIM ImmunoTech(AIM.US) With Buy Rating, Cuts Target Price to $1

Moomoo NewsOct 22 11:31 ET

Maxim Group Maintains AIM ImmunoTech(AIM.US) With Buy Rating, Cuts Target Price to $1

Moomoo NewsOct 22 09:31 ET

AIM ImmunoTech Analyst Ratings

BenzingaSep 3 06:09 ET

Buy Rating Affirmed: AIM ImmunoTech's Ampligen Shows Promising Oncology Pipeline Progress

TipRanksMay 17 14:00 ET

Analysts Offer Insights on Healthcare Companies: AIM ImmunoTech (AIM) and Avid Bioservices (CDMO)

TipRanksApr 30 06:45 ET

Buy Rating Affirmed for AIM ImmunoTech Amidst Promising Trials and Product Pipeline Developments

TipRanksFeb 15 13:45 ET

Strong Financial Position and Promising Clinical Trials Bolster Buy Rating for AIM ImmunoTech: An Analysis by Jason McCarthy

TipRanksNov 16, 2023 12:06 ET

Analysts Are Bullish on These Healthcare Stocks: AIM ImmunoTech (AIM), Microbot Medical (MBOT)

TipRanksAug 17, 2023 12:30 ET

Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX) and AIM ImmunoTech (AIM)

TipRanksMay 18, 2023 15:00 ET

Ascendiant Remains a Buy on AIM ImmunoTech (AIM)

TipRanksApr 7, 2023 04:20 ET

Maxim Group Sticks to Their Buy Rating for AIM ImmunoTech (AIM)

TipRanksApr 5, 2023 07:25 ET

AIM ImmunoTech (AIM) Receives a Buy From Maxim Group

TipRanksMar 1, 2023 14:31 ET

Maxim Group Keeps Their Buy Rating on AIM ImmunoTech (AIM)

TipRanksSep 1, 2022 07:50 ET

Maxim Group Sticks to Its Buy Rating for AIM ImmunoTech (AIM)

TipRanksAug 16, 2022 14:20 ET